Back to top

Tale of the Tape

Zacks Equity Research

Agios Pharmaceuticals (AGIO) Surges: Stock Moves 18.6% Higher
January 16, 2014


Save at Trade
Agios Pharmaceuticals, Inc. (AGIO - Analyst Report) was a big mover last session, as the company saw its shares rise by roughly 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 87% since Jan 6.

This biotechnology company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Agios Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Cardiovascular Systems Inc. (CSII - Analyst Report), Mead Johnson Nutrition Company (MJN - Analyst Report) and Advaxis, Inc. . While Cardiovascular Systems and Mead Johnson Nutrition Company hold a Zacks Rank #1 (Strong Buy), Advaxis carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>